Atovaquon-Proguanil-Mepha 250 / 100

Atovaquon-Proguanil-Mepha 250 / 100 is a medicine authorised by Swissmedic under authorisation number 67872. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 April 2021 and the authorisation is valid without a time limit. ATC code P01BB51 places the medicine in the group Antiprotozoals.

  • Dispensing category A
  • Authorisation number 67872
  • ATC P01BB51
  • Synthetic medicines
Authorisation data
Authorisation number67872
NameAtovaquon-Proguanil-Mepha 250 / 100
Full nameAtovaquon-Proguanil-Mepha 250 / 100, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeP01BB51
First authorisation29 April 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Atovaquon-Proguanil-Mepha 250 / 100, FilmtablettenA29 April 2021
2Atovaquon-Proguanil-Mepha Junior 62.5 / 25, FilmtablettenA29 April 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
112Tablette(n)P01BB5108.04.1.A
224Tablette(n)P01BB5108.04.1.A
312Tablette(n)P01BB5108.04.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Atovaquon-Proguanil-Mepha 250 / 100 authorised in Switzerland?

Yes. Atovaquon-Proguanil-Mepha 250 / 100 is authorised by Swissmedic under authorisation number 67872, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Atovaquon-Proguanil-Mepha 250 / 100 have?

Atovaquon-Proguanil-Mepha 250 / 100 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Atovaquon-Proguanil-Mepha 250 / 100?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com